PG
PFE icon

PEAK6 Group’s Pfizer PFE Stock Holding History

PEAK6 Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$5.42M Sell
157,573
-473,457
-75% -$16.2M 0.02% 730
2018
Q1 		$21.2M Buy
631,030
+571,795
+965% +$19.7M 0.09% 212
2017
Q4 		$2.04M Sell
59,235
-26,034
-31% -$888K 0.01% 1389
2017
Q3 		$2.89M Sell
85,269
-54,491
-39% -$1.75M 0.01% 1108
2017
Q2 		$4.45M Buy
139,760
+3,267
+2% +$103K 0.03% 776
2017
Q1 		$4.43M Buy
136,493
+16,759
+14% +$528K 0.04% 629
2016
Q4 		$3.69M Sell
119,734
-19,605
-14% -$599K 0.03% 881
2016
Q3 		$4.48M Buy
139,339
+65,243
+88% +$2.18M 0.03% 752
2016
Q2 		$2.48M Buy
+74,096
New +$2.36M 0.02% 1087
2016
Q1 		– Sell
-86,323
Closed -$2.64M – 4898
2015
Q4 		$2.64M Sell
86,323
-59,129
-41% -$1.86M 0.02% 1142
2015
Q3 		$4.33M Sell
145,452
-419,808
-74% -$13.5M 0.02% 997
2015
Q2 		$18M Buy
565,260
+408,003
+259% +$13.3M 0.11% 211
2015
Q1 		$5.19M Sell
157,257
-1,411,095
-90% -$44.9M 0.04% 659
2014
Q4 		$46.4M Buy
1,568,352
+1,183,220
+307% +$33.9M 0.35% 16
2014
Q3 		$10.8M Buy
385,132
+199,628
+108% +$5.6M 0.08% 288
2014
Q2 		$5.22M Buy
185,504
+56,389
+44% +$1.61M 0.05% 498
2014
Q1 		$3.94M Buy
129,115
+23,715
+23% +$707K 0.03% 785
2013
Q4 		$3.06M Buy
105,400
+94,649
+880% +$2.75M 0.02% 1094
2013
Q3 		$146K Sell
10,751
-559,990
-98% -$15.2M ﹤0.01% 3929
2013
Q2 		$15.2K Buy
+570,741
New +$15.8M 0.06% 175

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6 Group's PFE Position: Q2 2018 in Review

PEAK6 Group sold out of Pfizer (PFE) in Q2 2018, closing a stake of 412,038 shares — an estimated $14.1M sold.

PEAK6 Group first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $13.9M in Q1 2018. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • PEAK6 Group reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 412,038 Pfizer shares in Q2 2018, an estimated $14.1M.
  • PEAK6 Group first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
  • PEAK6 Group's Pfizer position peaked at $13.9M in Q1 2018.
  • 2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.